Dotmatics Limited

Dotmatics Limited

May 25, 2010 04:00 ET

The Paterson Institute for Cancer Research have Licensed the Entire Dotmatics Informatics Suite

BISHOPS STORTFORD, UNITED KINGDOM--(Marketwire - May 25, 2010) - Cutting edge informatics company Dotmatics Limited (Dotmatics) were selected by the Paterson Institute for Cancer Research (Paterson Institute) to provide a complete range of drug discovery informatics solutions. The Paterson Institute have licensed and implemented the entire Dotmatics software range including; Browser, Vortex, Studies, Register, Gateway, Pinpoint & Nucleus.

The Dotmatics suite will be used for all aspects of early stage drug discovery by providing integrated software from registration to reporting through data querying, data visualisation and assay management. The web-based deployment of the suite reduces IT overhead whilst providing unrivalled flexibility through its simple user interface.

Dr Allan Jordan, Head of Chemistry at The Paterson Institute said "We chose to implement the Dotmatics suite of applications in preference to solutions from other vendors because of the intuitive interface and close integration between data capture, retrieval, interrogation and analysis across both chemistry and biology. We were also impressed by the degree of configurability inherent within the system architecture. Our system went live in December 2009 and in the intervening time, we have been working closely with Dotmatics to customise and tailor the system to our specific requirements. We remain very impressed with both the quality and responsiveness of their support offering and look forward to a long-term working relationship."

Steve Gallagher, CEO of Dotmatics said "We are very excited to work with the Paterson Institute to create a fully integrated and highly efficient drug discovery platform. It's great to provide a complete informatics suite to an exciting institute and such a worthy cause."

Why is Dotmatics Chosen by Leading Pharmaceutical and Biotech Companies?

Our web-based knowledge solutions dramatically improve the way scientific data is queried, browsed, managed, shared and visualised within companies. Dotmatics has significant expertise in cheminformatics techniques including chemical databases, SAR analysis, data management and data visualization. Overall we enhance the strategic decision making process, saving time and money whilst enriching the day to day lives of research scientists.

The Dotmatics suite includes:

Browser- a query and visualization tool for biological and chemical datasets.

Vortex - world-class visualization and analytics platform for scientific and non-scientific data.

Studies - the new standard in screening data management.

Studies Notebook - a completely web-based ELN running on Windows™ or Apple Macs™ and supporting chemistry, biology and ad-hoc research.

Pinpoint(1)- an Oracle cartridge allowing rapid indexing and searching of chemical databases.

Gateway- a centralised depot for sharing information with colleagues and external collaborators.

Nucleus- a web-based tool for importing, mapping and storing data from existing sources.

Register- a web-based tool for single and batch compound registration.

For further information please visit www.dotmatics.com.

(1) Pinpoint is developed in collaboration with Astex Therapeutics Ltd

Notes to Editors.

Paterson Institute for Cancer Research

The Paterson is a research institute within The University of Manchester, and is one of five research institutes core-funded by Cancer Research UK. It is a partner in the Manchester Cancer Research Centre (MCRC), whose goal is to become one of the world's leading cancer research centres. The MCRC brings together the cancer research activity in the city and was founded by The University of Manchester, The Christie NHS Foundation Trust and Cancer Research UK.

Research at the Paterson Institute spans the whole spectrum of cancer research, from programmes investigating the molecular and cellular basis of cancer to those focused on translational research and the development of novel therapeutic approaches. Facilities include micro-arrays, advanced imaging, bioinformatics and state-of-the-art mass-spectrometry based proteomics. The Institute has over 400 postdoctoral scientists, clinical fellows, scientific officers, administrative and technical staff, postgraduate research students and visiting fellows. For more information please visit www.paterson.man.ac.uk.

Contact Information